✦ LIBER ✦

No mutations of FGFR3 in normal urothelium in the vicinity of urothelial carcinoma of the bladder harbouring activating FGFR3 mutations in patients with bladder cancer

✍ Scribed by Wolfgang Otto; Stefan Denzinger; Simone Bertz; Andreas Gaumann; Peter J. Wild; Arndt Hartmann; Robert Stoehr

Publisher: John Wiley and Sons
Year: 2009
Tongue: French
Weight: 94 KB
Volume: 125
Category: Article
ISSN: 0020-7136
DOI: 10.1002/ijc.24598

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Mutations in the fibroblast growth factor receptor 3 (FGFR3) gene causing constitutive oncogenic protein activation have been shown to be frequent in papillary noninvasive bladder tumours and are associated with a low risk of progression and a favourable outcome. FGFR3 alterations have also been found in benign urothelial papilloma and flat urothelial hyperplasia suggesting FGFR3 alterations as an early event in bladder tumorigenesis. To date there is no data available on FGFR3 mutations in normal urothelium from patients with bladder cancer. We therefore analysed 64 samples of histopathological unsuspicious normal urothelium from 38 patients with FGFR3 mutated bladder tumours and 15 samples of urothelium from patients (n = 15) without any urothelial malignancy as a control group. Urothelial cells were microdissected from formalin‐fixed, paraffin‐embedded material. After DNA isolation whole genome amplification was done by I‐PEP‐PCR. FGFR3 mutations were detected using SNaPshot analysis. All samples could successfully be investigated. FGFR3 analyses did not reveal any mutation in the urothelium from neither the control group nor the bladder cancer group. All urothelial samples showed a wildtype sequence for FGFR3. These data suggest that mutations in the FGFR3 gene are not the earliest genetic alterations in bladder carcinogenesis and are associated with a hyperproliferative (hyperplastic) phenotype in the urothelium. Chromosomal alterations like deletions on chromosome 9q or aberrant promoter hypermethylation could play more important roles in early urothelial transformation than mutational FGFR3 activation. © 2009 UICC

📜 SIMILAR VOLUMES

Chromosome 9 deletions are more frequent

Chromosome 9 deletions are more frequent than FGFR3 mutations in flat urothelial hyperplasias of the bladder

✍ Johanna M.M. van Oers; Christoph Adam; Stefan Denzinger; Robert Stoehr; Simone B 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 209 KB

## Abstract Flat urothelial hyperplasias (FUHs) in patients with papillary bladder tumours frequently show deletions of chromosome 9, suggesting that FUH could be the first neoplastic step in the development of papillary bladder cancer. __FGFR3__ mutations are frequent in non‐invasive papillary tum

Occupational exposure to polycyclic arom

Occupational exposure to polycyclic aromatic hydrocarbons influenced neither the frequency nor the spectrum of FGFR3 mutations in bladder urothelial carcinoma

✍ Ashraf A. Bakkar; Yves Allory; Yuriko Iwatsubo; Sixtina Gil Diez de Medina; Pasc 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB

Constitutive activating mutation of the

Constitutive activating mutation of the FGFR3b in oral squamous cell carcinomas

✍ Yan Zhang; Yoshiko Hiraishi; Hua Wang; Ken-saku Sumi; Yasutaka Hayashido; Shigea 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 200 KB

A G to T mutation at nucleotide position 2128 in the human FGFR3b coding region resulting in a Cys for Gly substitution (G697C) in the tyrosine kinase domain was observed in 62% (44/71) of oral squamous cell carcinomas (OSCC) examined. Immunostained FGFR3b was found in the cytoplasm of prickle cells

The incidence of thanatophoric dysplasia

The incidence of thanatophoric dysplasia mutations in FGFR3 gene is higher in low-grade or superficial bladder carcinomas

✍ Takahiro Kimura; Hideaki Suzuki; Toya Ohashi; Kouji Asano; Hiroshi Kiyota; Yoshi 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB 👁 1 views